Jaguar Animal Health (NASDAQ:JAGX) Share Price Crosses Above 50 Day Moving Average – Here’s What Happened

Jaguar Animal Health, Inc. (NASDAQ:JAGX) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.83 and traded as high as $0.9221. Jaguar Animal Health shares last traded at $0.8879, with a volume of 925,275 shares traded.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of Jaguar Animal Health in a report on Thursday, January 22nd. Wall Street Zen lowered shares of Jaguar Animal Health to a “strong sell” rating in a research note on Friday, January 23rd. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $60.00.

Jaguar Animal Health Stock Performance

The company has a debt-to-equity ratio of 4.08, a current ratio of 0.81 and a quick ratio of 0.52. The firm has a market cap of $3.32 million, a price-to-earnings ratio of -0.03 and a beta of 0.09. The firm has a fifty day simple moving average of $0.83 and a two-hundred day simple moving average of $1.45.

Jaguar Animal Health’s stock is going to split on the morning of Monday, March 2nd. The 1.1-1 split was recently announced. The newly minted shares will be payable to shareholders after the market closes on Sunday, March 1st.

About Jaguar Animal Health

Jaguar Animal Health, Inc is a biopharmaceutical company focused on the development and commercialization of novel therapeutics for the gastrointestinal health of food-producing animals, with an emphasis on swine and poultry. The company’s research and development efforts target common enteric disorders such as post-weaning diarrhea in pigs and clostridial overgrowth in broiler chickens, aiming to provide effective alternatives to traditional antibiotic treatments.

Jaguar Animal Health was formed in early 2019 through the acquisition of the animal health business of Aratana Therapeutics by Actinium Animal Health, followed by a corporate rebranding.